Spinosad Suspension
Product Images NDC 28595-570

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Spinosad (NDC 28595-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spinosad 01)

FDA Label Image

Chemical Structure (Spinosad 02)

FDA Label Image

Step 1 (Spinosad 03)

FDA Label Image

Step 2 (Spinosad 04)

FDA Label Image

Step 3 (Spinosad 05)

FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

FDA Label Image

Spinosad 07

FDA Label Image

Spinosad 08

FDA Label Image

Spinosad 09

FDA Label Image

Spinosad 10

FDA Label Image

Spinosad 11

FDA Label Image

Spinosad 12

FDA Label Image

Spinosad 13

This text seems to be a set of directions for a topical suspension called Spinosad. It provides information on how to use the product, the recommended dosage, and precautions to take when using it. It includes a list of ingredients and advises to avoid contact with eyes and to keep the product out of reach of children. There is also information on how to handle eye contact and where to store the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.